Orlans HO - Search Results

1

Developmental Expression of the Cell Cycle Regulator p16^INK4a in Retinal Glial Cells: A Novel Marker for Immature Ocular Astrocytes?

Martinez-Fernandez de la Camara C, Storm T, Salman A, Burgoyne T, Rasmussen MQ, Orlans HO, Russell AJ, Davies SG, Barnard AR, MacLaren RE. Martinez-Fernandez de la Camara C, et al. Among authors: orlans ho. J Histochem Cytochem. 2023 Jun;71(6):301-320. doi: 10.1369/00221554231184286. Epub 2023 Jun 23. J Histochem Cytochem. 2023. PMID: 37350564 Free PMC article.

2

A Novel Postoperative Drop Regimen Reduces Risk of Ocular Hypertension Following Pars Plana Vitrectomy.

Orlans HO, Yazdouni S, Williamson TH, Wong RS, Laidlaw DAH. Orlans HO, et al. Ophthalmologica. 2023;246(1):32-38. doi: 10.1159/000528037. Epub 2022 Dec 23. Ophthalmologica. 2023. PMID: 36566742

3

Using QR smartphone technology to improve patient communication and information distribution.

Azad A, Laidlaw DAH, Orlans HO. Azad A, et al. Among authors: orlans ho. Eye (Lond). 2022 Jun;36(6):1321-1322. doi: 10.1038/s41433-021-01757-x. Epub 2021 Aug 30. Eye (Lond). 2022. PMID: 34462585 Free PMC article. No abstract available.

4

Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa.

Orlans HO, McClements ME, Barnard AR, Martinez-Fernandez de la Camara C, MacLaren RE. Orlans HO, et al. Nat Commun. 2021 Aug 16;12(1):4934. doi: 10.1038/s41467-021-25204-3. Nat Commun. 2021. PMID: 34400638 Free PMC article.

5

Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study.

Corazza P, D'Alterio FM, Kabbani J, Alam MMR, Mercuri S, Orlans HO, Younis S. Corazza P, et al. Among authors: orlans ho. BMC Ophthalmol. 2021 Aug 14;21(1):300. doi: 10.1186/s12886-021-02055-6. BMC Ophthalmol. 2021. PMID: 34391401 Free PMC article.

6

Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine Model.

Orlans HO, Barnard AR, Patrício MI, McClements ME, MacLaren RE. Orlans HO, et al. Hum Gene Ther. 2020 Jul;31(13-14):730-742. doi: 10.1089/hum.2020.008. Epub 2020 Jun 26. Hum Gene Ther. 2020. PMID: 32394751

7

Vascular Density and Retinal Function in Patients with Retinitis Pigmentosa Evaluated by Swept-Source OCT Angiography and Microperimetry.

Corazza P, Cirafici P, Testa V, Orlans HO, Berisso M, Traverso CE, Vagge A, Nicolò M. Corazza P, et al. Among authors: orlans ho. Ophthalmologica. 2021;244(1):27-33. doi: 10.1159/000507961. Epub 2020 Apr 20. Ophthalmologica. 2021. PMID: 32305973

8

Dynamic in vivo quantification of rod photoreceptor degeneration using fluorescent reporter mouse models of retinitis pigmentosa.

Orlans HO, Barnard AR, MacLaren RE. Orlans HO, et al. Exp Eye Res. 2020 Jan;190:107895. doi: 10.1016/j.exer.2019.107895. Epub 2019 Dec 6. Exp Eye Res. 2020. PMID: 31816293

9

Comment on: 'Sector retinitis pigmentosa caused by mutations of the RHO gene'.

Orlans HO, MacLaren RE. Orlans HO, et al. Eye (Lond). 2020 Aug;34(8):1477-1478. doi: 10.1038/s41433-019-0648-z. Epub 2019 Oct 28. Eye (Lond). 2020. PMID: 31659286 Free PMC article. No abstract available.

10

Filtration of Short-Wavelength Light Provides Therapeutic Benefit in Retinitis Pigmentosa Caused by a Common Rhodopsin Mutation.

Orlans HO, Merrill J, Barnard AR, Charbel Issa P, Peirson SN, MacLaren RE. Orlans HO, et al. Invest Ophthalmol Vis Sci. 2019 Jun 3;60(7):2733-2742. doi: 10.1167/iovs.19-26964. Invest Ophthalmol Vis Sci. 2019. PMID: 31247114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters